lysophosphatidylethanolamine 0:0/20:4(8Z,11Z,14Z,17Z)

Term ID

CHEBI:72746

Synonyms

(2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
LPE 0:0/20:4(8Z,11Z,14Z,17Z)
LPE(0:0/20:4(8Z,11Z,14Z,17Z))
Lyso-PE(0:0/20:4(8Z,11Z,14Z,17Z))
LysoPE(0:0/20:4(8Z,11Z,14Z,17Z))
PE 0:0/20:4(8Z,11Z,14Z,17Z)
PE(0:0/20:4(8Z,11Z,14Z,17Z))

Definition

A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 8Z,11Z,14Z,17Z-eicosapentaenoyl (omega-3-arachidonoyl).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 2-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 20:4

2-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 20:4 Show first 5 Terms
has_functional_parent: all-cis-8,11,14,17-icosatetraenoic acid

all-cis-8,11,14,17-icosatetraenoic acid Show first 5 Terms
has_role: metabolite

metabolite Show first 5 Terms

Phenotype

Phenotype resulting from lysophosphatidylethanolamine 0:0/20:4(8Z,11Z,14Z,17Z)

Phenotype where environments contain lysophosphatidylethanolamine 0:0/20:4(8Z,11Z,14Z,17Z)

Phenotype modified by environments containing lysophosphatidylethanolamine 0:0/20:4(8Z,11Z,14Z,17Z)

Human Disease Model